Patents by Inventor Tony Hugli

Tony Hugli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220273559
    Abstract: Provided herein are formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.
    Type: Application
    Filed: May 7, 2022
    Publication date: September 1, 2022
    Applicants: Healthaide Inc., Jupiter Wellness, Inc.
    Inventors: Tony Hugli, Glynn Wilson
  • Publication number: 20220273611
    Abstract: Provided herein are oronasal formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.
    Type: Application
    Filed: May 7, 2022
    Publication date: September 1, 2022
    Applicants: Healthaide Inc., Jupiter Wellness, Inc.
    Inventors: Tony Hugli, Glynn Wilson
  • Publication number: 20210393576
    Abstract: Provided herein are oronasal formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.
    Type: Application
    Filed: June 21, 2021
    Publication date: December 23, 2021
    Inventors: Glynn Wilson, Tony Hugli
  • Publication number: 20210038513
    Abstract: Provided herein are formulations including a cannabinoid and N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM). Also provided are methods of using the formulations.
    Type: Application
    Filed: August 7, 2020
    Publication date: February 11, 2021
    Inventors: Glynn Wilson, Tony Hugli
  • Publication number: 20050277597
    Abstract: A method and formulation for treating skin for sunburn and other types of burns is disclosed. The method comprises the topical application of a preparation comprising N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester and its lower alkyl ester derivatives.
    Type: Application
    Filed: June 8, 2005
    Publication date: December 15, 2005
    Applicant: Oklahoma Medical Research Foundation
    Inventors: Carl Manion, Allen Edmundson, John Adams, Tony Hugli
  • Publication number: 20050220708
    Abstract: Non-allergic hypersensitivity reactions can be observed in a subject in response to anaphylatoxins. Accordingly methods are provided for detecting non-allergic hypersensitivity in a subject referred to as “pseudo-allergic reactions”. Also provided are kits for detecting non-allergic hypersensitivity and hyper-responsiveness in a subject.
    Type: Application
    Filed: October 27, 2004
    Publication date: October 6, 2005
    Inventor: Tony Hugli
  • Patent number: 6534283
    Abstract: Shock is a life threatening complication in situations associated with trauma including burns, surgery, ischemia, sepsis, and other critical care applications. Shock is induced by pancreatic proteases when they are released into the small intestine when the tissue is compromised due to trauma. Administration of protease inhibitors into the small intestine, either orally, intraveneously, or by direct lavage, was demonstrated to prevent shock in rats as determined by both survival time and molecular and histological analysis.
    Type: Grant
    Filed: November 22, 2000
    Date of Patent: March 18, 2003
    Assignees: The Regents of the University of California, The Scripps Institute
    Inventors: Geert Schmid-Schoenbein, Tony Hugli, Hiroshi Mitsuoka